Invesco’s China SXT Pharmaceuticals SXTC Stock Holding History

Invesco’s Portfolio SXTC Stock Details SXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$137K	–	3821
2025 Q4	$137K	Hold	7	–	–	﹤0.01%	3604
2025 Q3	$141K	Buy	+7	New	+$138K	﹤0.01%	3629
2019 Q3	–	Hold	0	–	-$88K	–	3719
2019 Q2	–	Hold	0	–	–	–	3688

Other funds holding SXTC

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco's SXTC Position: Q1 2026 in Review

Invesco sold out of China SXT Pharmaceuticals (SXTC) in Q1 2026, closing a stake of 7 shares — an estimated $137K sold.

Invesco first reported a position in SXTC in Q3 2025 and held it in 2 quarters. The position peaked at $141K in Q3 2025. 1 fund tracked by Wall St. Rank holds SXTC as of Q1 2026.

Invesco reported no remaining China SXT Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Invesco sold 7 China SXT Pharmaceuticals shares in Q1 2026, an estimated $137K.
Invesco first reported a position in China SXT Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Invesco's China SXT Pharmaceuticals position peaked at $141K in Q3 2025.
1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.